Even after many cancer-free years, the fear of recurrence still lingers, and many long-term survivors struggle to keep those ...

CX-2051 treatment demonstrated responses in patients with advanced, late-line colorectal cancer, according to interim data ...

The U.S. FDA has approved treatment with Emrelis for adult patients with previously treated, advanced NSCLC with high c-Met ...

The addition of Erleada to ADT may provide less benefit in patients with metastatic castration-sensitive prostate cancer and ...